-
公开(公告)号：US20060246128A1
公开(公告)日：2006-11-02
申请号：US11412022
申请日：2006-04-26
CPC分类号： A61K31/536 , A61K9/14 , A61K9/141 , A61K9/2018 , A61K9/2054 , A61K9/4808 , A61K9/4866
摘要： The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, and magnesium stearate; or can contain microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, povidone, and magnesium stearate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefore Additional uses include stimulation of food intake.
摘要翻译： 本发明提供了组合物，理想的药物组合物，其含有微粉化的tanaproget。 组合物还可以含有微晶纤维素，交联羧甲基纤维素钠，无水乳糖和硬脂酸镁; 或可以含有微晶纤维素，交联羧甲基纤维素钠，十二烷基硫酸钠，聚维酮和硬脂酸镁。 该组合物可用于避孕和激素替代治疗以及治疗和/或预防子宫肌层肌瘤，良性前列腺肥大，良性和恶性肿瘤性疾病，功能障碍性出血，子宫平滑肌瘤，子宫内膜异位症，多囊卵巢综合征，以及癌和腺癌 垂体，子宫内膜，肾，卵巢，乳腺，结肠，前列腺和其他激素依赖性肿瘤，以及因此有用的药物的制备其他用途包括刺激食物摄入。
-
公开(公告)号：US20060247234A1
公开(公告)日：2006-11-02
申请号：US11412014
申请日：2006-04-26
IPC分类号： A61K31/536 , A61K9/48
CPC分类号： A61K31/575 , A61K9/145 , A61K9/1641 , A61K9/1652 , A61K9/4858 , A61K9/4866 , A61K31/536 , A61K45/00 , A61K45/06
摘要： Compositions, preferably pharmaceutical compositions, containing micronized tanaproget, or pharmaceutically acceptable salt thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, butylated hydroxyanisole, povidone, and magnesium stearate, are provided. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
-
公开(公告)号：US08664208B2
公开(公告)日：2014-03-04
申请号：US13292405
申请日：2011-11-09
申请人： Arwinder Nagi , Ramarao Chatlapalli , Shamim Hasan , Zafar Ali , Mohamed Ghorab
发明人： Arwinder Nagi , Ramarao Chatlapalli , Shamim Hasan , Zafar Ali , Mohamed Ghorab
IPC分类号： A61K31/56 , A61K31/535
CPC分类号： A61K31/567 , A61K9/1623 , A61K9/1652 , A61K9/1682 , A61K9/2018 , A61K9/2054 , A61K9/2077 , A61K9/2095 , A61K9/4808 , A61K31/00 , A61K31/536 , A61K31/538 , A61K31/56 , A61K31/565 , A61K2300/00
摘要： Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits containing the compositions, methods of contraception and hormone replacement therapy including administering a composition containing micronized tanaproget and ethinyl estradiol.
摘要翻译： 提供了含有微粉化的tanaproget或其药学上可接受的盐和乙炔雌二醇的组合物及其制备方法。 还提供了包含组合物，避孕方法和激素替代疗法的试剂盒，其包括施用含有微粉化的萘普生和乙炔雌二醇的组合物。
-
公开(公告)号：US20060280800A1
公开(公告)日：2006-12-14
申请号：US11448965
申请日：2006-06-07
申请人： Arwinder Nagi , Ramarao Chatlapalli , Shamim Hasan , Zafar Ali , Mohamed Ghorab
发明人： Arwinder Nagi , Ramarao Chatlapalli , Shamim Hasan , Zafar Ali , Mohamed Ghorab
IPC分类号： A61K31/56 , A61K9/14 , A61K31/538
CPC分类号： A61K31/567 , A61K9/1623 , A61K9/1652 , A61K9/1682 , A61K9/2018 , A61K9/2054 , A61K9/2077 , A61K9/2095 , A61K9/4808 , A61K31/00 , A61K31/536 , A61K31/538 , A61K31/56 , A61K31/565 , A61K2300/00
摘要： Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits containing the compositions, methods of contraception and hormone replacement therapy including administering a composition containing micronized tanaproget and ethinyl estradiol.
摘要翻译： 提供了含有微粉化的tanaproget或其药学上可接受的盐和乙炔雌二醇的组合物及其制备方法。 还提供了包含组合物，避孕方法和激素替代疗法的试剂盒，其包括施用含有微粉化的萘普生和乙炔雌二醇的组合物。
-
公开(公告)号：US20060246135A1
公开(公告)日：2006-11-02
申请号：US11411523
申请日：2006-04-26
IPC分类号： A61K9/26
CPC分类号： A61K9/16 , A61K9/0002 , A61K9/167 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/2077 , A61K31/536
摘要： The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, magnesium stearate, micronized edetate calcium disodium hydrous, and micronized sodium thiosulfate pentahydrate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
-
公开(公告)号：US20120114748A1
公开(公告)日：2012-05-10
申请号：US13292405
申请日：2011-11-09
申请人： Arwinder Nagi , Ramarao Chatlapalli , Shamim Hasan , Zafar Ali , Mohamed Ghorab
发明人： Arwinder Nagi , Ramarao Chatlapalli , Shamim Hasan , Zafar Ali , Mohamed Ghorab
IPC分类号： A61K31/567 , A61P15/18 , A61P5/24 , A61K9/48
CPC分类号： A61K31/567 , A61K9/1623 , A61K9/1652 , A61K9/1682 , A61K9/2018 , A61K9/2054 , A61K9/2077 , A61K9/2095 , A61K9/4808 , A61K31/00 , A61K31/536 , A61K31/538 , A61K31/56 , A61K31/565 , A61K2300/00
摘要： Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits containing the compositions, methods of contraception and hormone replacement therapy including administering a composition containing micronized tanaproget and ethinyl estradiol.
摘要翻译： 提供了含有微粉化的tanaproget或其药学上可接受的盐和乙炔雌二醇的组合物及其制备方法。 还提供了包含组合物，避孕方法和激素替代疗法的试剂盒，其包括施用含有微粉化的萘普生和乙炔雌二醇的组合物。
-
7.发明申请PHARMACEUTICAL FORMULATIONS OF A CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL 审中-公开2-（3-氟-4-羟基苯基）-7-乙烯基-1,3-苯并恶唑-5-OL的晶体形式的药物制剂公开(公告)号：US20080175901A1
公开(公告)日：2008-07-24
申请号：US11942786
申请日：2007-11-20
申请人： Mahesh K. Krishnan , Mohamed Ghorab , Rolland W. Carson , Shamim Hasan , Arwinder Nagi , Patricia Carson
发明人： Mahesh K. Krishnan , Mohamed Ghorab , Rolland W. Carson , Shamim Hasan , Arwinder Nagi , Patricia Carson
IPC分类号： A61K9/48 , A61K31/423
CPC分类号： A61K9/4858 , A61K9/2018 , A61K9/2054 , A61K9/4866 , A61K31/423
摘要： The present invention is directed to pharmaceutical formulations of a crystal form of an estrogen receptor modulator, and pharmaceutical compositions and preparative processes thereof.
摘要翻译： 本发明涉及结晶形式的雌激素受体调节剂的药物制剂及其药物组合物及其制备方法。
-
公开(公告)号：US07786297B2
公开(公告)日：2010-08-31
申请号：US11412016
申请日：2006-04-26
申请人： Ramarao Chatlapalli , Arwinder Nagi , John Potoski , Jean Louise Helom , Bogdan Kazimierz Wilk , Arkadiy Zinoviy Rubezhov , Vladimir Dragan
发明人： Ramarao Chatlapalli , Arwinder Nagi , John Potoski , Jean Louise Helom , Bogdan Kazimierz Wilk , Arkadiy Zinoviy Rubezhov , Vladimir Dragan
IPC分类号： C07D265/14
CPC分类号： C07D265/14 , C07D413/04
摘要： Micronized tanaproget, purified tanaproget Form I, and micronized, purified tanaproget Form I are provided. Also provided are compositions containing one or more of the prepared tanaproget forms, methods of using one or more of the prepared tanaproget forms, and kits containing one or more of the prepared tanaproget forms.
摘要翻译： 提供微粉化的钠盐瓶，纯化的tanaproget Form I和微粉化的纯化的Tanaproget Form I。 还提供了含有一种或多种所制备的钛酸钠形式的组合物，使用一种或多种所制备的钛酸钠形式的方法，以及包含一种或多种所制备的钛酸钠形式的试剂盒。
-
公开(公告)号：US20070003623A1
公开(公告)日：2007-01-04
申请号：US11478400
申请日：2006-06-28
CPC分类号： A61K9/209 , A61K31/55 , A61K31/565
摘要： The present invention relates to solid dosage formulations containing conjugated estrogens and bazedoxifene, or a salt thereof. In some embodiments, the compositions include a core comprising conjugated estrogens, and at least one coating that comprises bazedoxifene, or a salt thereof.
摘要翻译： 本发明涉及含有结合雌激素和巴多昔芬或其盐的固体剂型。 在一些实施方案中，组合物包括包含共轭雌激素的核心和至少一种包含巴西多昔芬或其盐的包衣。
-
公开(公告)号：US20060247236A1
公开(公告)日：2006-11-02
申请号：US11412016
申请日：2006-04-26
申请人： Ramarao Chatlapalli , Arwinder Nagi , John Potoski , Jean Helom , Bogdan Wilk , Arkadiy Rubezhov , Vladimir Dragan
发明人： Ramarao Chatlapalli , Arwinder Nagi , John Potoski , Jean Helom , Bogdan Wilk , Arkadiy Rubezhov , Vladimir Dragan
IPC分类号： A61K31/538 , C07D413/02
CPC分类号： C07D265/14 , C07D413/04
摘要： Micronized tanaproget, purified tanaproget Form I, and micronized, purified tanaproget Form I are provided. Also provided are compositions containing one or more of the prepared tanaproget forms, methods of using one or more of the prepared tanaproget forms, and kits containing one or more of the prepared tanaproget forms.
摘要翻译： 提供微粉化的钠盐瓶，纯化的tanaproget Form I和微粉化的纯化的Tanaproget Form I。 还提供了含有一种或多种所制备的钛酸钠形式的组合物，使用一种或多种所制备的钛酸钠形式的方法，以及包含一种或多种所制备的钛酸钠形式的试剂盒。
-
-
-
-
-
-
-
-
-
搜索结果
21 条记录 (耗时 0.023 秒)
